New drug trial targets rare liver disease
NCT ID NCT05896137
Summary
This study is testing an investigational drug called CS0159 for people with Primary Sclerosing Cholangitis (PSC), a rare disease that scars the bile ducts in the liver. About 50 participants will be randomly assigned to receive either the drug or a placebo for 12 weeks, followed by a longer open period. The main goals are to see if the drug is safe and if it can lower a key liver enzyme (ALP) that indicates disease activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Captail Medcial University
Beijing, Beijing Municipality, 100050, China
-
Beijing YouAn Hostital, Captial Medical University
Beijing, Beijing Municipality, 100069, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, China
-
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200120, China
-
Shaoyifu Hospital of Zhejiang University Medical
Hangzhou, Zhejiang, 310000, China
-
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Hefei, Anhui, China
-
The First Affiliated Hospital,Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
-
The Seconed Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
Wuhan Union Hospital of China
Wuhan, Hubei, 430022, China
Conditions
Explore the condition pages connected to this study.